Sage Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	315,316	166,412	33,801	12,496	32,101	33,538	Upgrade
Market Cap Growth	288.07%	392.33%	170.49%	-61.07%	-4.28%	-	Upgrade
Enterprise Value	310,906	162,339	31,118	10,416	30,105	32,228	Upgrade
PE Ratio	597.18	372.76	178.06	-	-	-	Upgrade
PS Ratio	109.41	60.12	16.79	7.01	23.68	37.55	Upgrade
PB Ratio	61.75	33.82	10.49	5.05	15.94	26.95	Upgrade
P/TBV Ratio	62.83	34.56	10.83	5.21	15.94	26.95	Upgrade
P/FCF Ratio	-	150.97	53.60	72.69	113.65	-	Upgrade
P/OCF Ratio	-	149.31	52.46	59.69	109.35	-	Upgrade
EV/Sales Ratio	115.24	58.65	15.46	5.84	22.21	36.08	Upgrade
EV/EBITDA Ratio	-	491.45	224.34	-	-	-	Upgrade
EV/EBIT Ratio	-	541.46	286.72	-	-	-	Upgrade
EV/FCF Ratio	254.89	147.27	49.34	60.59	106.58	-	Upgrade
Debt / Equity Ratio	0.04	0.05	0.06	0.09	0.11	0.30	Upgrade
Debt / EBITDA Ratio	0.51	0.61	1.11	-	-	-	Upgrade
Debt / FCF Ratio	0.19	0.21	0.33	1.36	0.81	-	Upgrade
Asset Turnover	0.54	0.53	0.56	0.57	0.52	0.51	Upgrade
Quick Ratio	6.36	5.83	5.41	4.92	4.11	3.59	Upgrade
Current Ratio	6.49	5.96	5.55	5.17	4.34	3.74	Upgrade
Return on Equity (ROE)	12.36%	10.81%	7.01%	-15.04%	-27.29%	-139.76%	Upgrade
Return on Assets (ROA)	4.39%	3.57%	1.88%	-3.00%	-8.65%	-34.24%	Upgrade
Return on Capital (ROIC)	5.15%	4.25%	2.24%	-3.70%	-11.34%	-58.17%	Upgrade
Return on Capital Employed (ROCE)	7.00%	5.80%	3.20%	-	-	-	Upgrade
Earnings Yield	0.17%	0.27%	0.56%	-2.80%	-1.43%	-2.84%	Upgrade
FCF Yield	0.39%	0.66%	1.87%	1.38%	0.88%	-0.75%	Upgrade
Buyback Yield / Dilution	-6.20%	-6.65%	-11.34%	-7.29%	-96.42%	-69.74%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.